BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20447533)

  • 1. Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.
    Saraf S; Christopoulos C; Salha IB; Stott DJ; Gorog DA
    J Am Coll Cardiol; 2010 May; 55(19):2107-15. PubMed ID: 20447533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
    Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
    Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.
    Bonello L; De Labriolle A; Lemesle G; Steinberg DH; Roy P; Torguson R; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):866-70. PubMed ID: 19198009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL; Morrow DA; de Lemos JA; Mohanavelu S; Cannon CP; Sabatine MS
    J Am Coll Cardiol; 2008 Jun; 51(25):2422-9. PubMed ID: 18565400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease.
    Sharma S; Farrington K; Kozarski R; Christopoulos C; Niespialowska-Steuden M; Moffat D; Gorog DA
    Eur Heart J; 2013 Feb; 34(5):354-63. PubMed ID: 23048192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
    Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?
    Ulus T; Yildirir A; Sade LE; Temiz A; Polat E; Bozbaş H; Aydinalp A; Eroğlu S; Ozin B; Müderrisoğlu H
    Coron Artery Dis; 2008 Nov; 19(7):489-95. PubMed ID: 18923245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
    Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
    Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome.
    Taglieri N; Saia F; Rapezzi C; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Ortolani P; Melandri G; Rosmini S; Cinti L; Alessi L; Vagnarelli F; Villani C; Branzi A; Marzocchi A
    Thromb Haemost; 2011 Jul; 106(1):132-40. PubMed ID: 21614413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes.
    Nabais S; Losa N; Gaspar A; Rocha S; Costa J; Azevedo P; Basto L; Pereira MA; Correia A
    Rev Port Cardiol; 2009 Sep; 28(9):905-24. PubMed ID: 19998803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
    Christopoulos C; Farag M; Sullivan K; Wellsted D; Gorog DA
    Thromb Haemost; 2017 Feb; 117(3):457-470. PubMed ID: 28004059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
    de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
    J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
    van Oijen MG; Claessen BE; Clappers N; van Schaik A; Laheij RJ; Jansen JB; Peters WH; Verheugt FW
    Am J Cardiol; 2008 Jul; 102(2):135-9. PubMed ID: 18602509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort.
    Li N; Li S; Yu C; Gu S
    Postgrad Med; 2010 Jul; 122(4):200-5. PubMed ID: 20675983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.